Friday 6 November 2026 Export PLSE’s income statement to Excel — free account

Pulse Biosciences, Inc

PLSE Healthcare Medical Instruments & Supplies

Pulse Biosciences, Inc’s revenue for fiscal 2025 (year ended December 2025) was $350,000.00, down 50.0% from fiscal 2022.

Revenue: +359.3%
EPS: −10.3%
Free cash flow: −1,180.5%

Quarter to September 2026, against a year earlier

Insider buying

53.15 3.91 −6.85%

Follow PLSE

Alert me

Market cap: $3.9B
P/E: 0.0×
Fwd P/E: −38.1×
Dividend yield: —
F-score: n/a
Altman Z: 31.41
Beneish M: n/a
Dividend safety: n/a

Overview

Pulse Biosciences, Inc (PLSE) Price to free cash flow

Alert me on Price to free cash flow

Pulse Biosciences, Inc has no meaningful price to free cash flow: its trailing twelve-month free cash flow is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/PLSE/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="Pulse Biosciences, Inc price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/PLSE/metrics/price-to-free-cash-flow">Pulse Biosciences, Inc (PLSE) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	0.0×	—
FY2022	0.0×	—
FY2021	0.0×	—

Period	Price to free cash flow	Change
Sep 2026	0.0×	—
Jun 2026	0.0×	—
Mar 2026	0.0×	—
Dec 2025	0.0×	—
6 more quarters	Free account

Against its own ten years

Low 0.0× High 0.0×

Ten-year median 0.0×

Current reading's percentile 100

Company	Price to free cash flow
STVN Stevanato Group S.p.A. compare	n/m
PLSE Pulse Biosciences, Inc	n/m
MMED MiniMed Group, Inc. compare	n/m
NVST Envista Holdings Corporation compare	16.4×
ICUI ICU Medical, Inc. compare	21.2×
MMSI Merit Medical Systems, Inc. compare	23.6×
TFX Teleflex Incorporated compare	125×
ATRC AtriCure, Inc. compare	129×
WRBY Warby Parker Inc. compare	153×
Medical Instruments & Supplies industry median	23.5×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

Pulse Biosciences, Inc (PLSE) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on PLSE

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on PLSE

Stockrow Weekly